213 related articles for article (PubMed ID: 19705104)
1. Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.
Miskowiak KW; Favaron E; Hafizi S; Inkster B; Goodwin GM; Cowen PJ; Harmer CJ
Psychopharmacology (Berl); 2009 Nov; 207(1):133-42. PubMed ID: 19705104
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients.
Miskowiak KW; Favaron E; Hafizi S; Inkster B; Goodwin GM; Cowen PJ; Harmer CJ
Psychopharmacology (Berl); 2010 Jun; 210(3):419-28. PubMed ID: 20401747
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin reduces neural and cognitive processing of fear in human models of antidepressant drug action.
Miskowiak K; O'Sullivan U; Harmer CJ
Biol Psychiatry; 2007 Dec; 62(11):1244-50. PubMed ID: 17553466
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration.
Miskowiak K; Inkster B; Selvaraj S; Wise R; Goodwin GM; Harmer CJ
Neuropsychopharmacology; 2008 Feb; 33(3):611-8. PubMed ID: 17473836
[TBL] [Abstract][Full Text] [Related]
5. The effects of reboxetine on emotional processing in healthy volunteers: an fMRI study.
Norbury R; Mackay CE; Cowen PJ; Goodwin GM; Harmer CJ
Mol Psychiatry; 2008 Nov; 13(11):1011-20. PubMed ID: 17955021
[TBL] [Abstract][Full Text] [Related]
6. Neural correlates of improved executive function following erythropoietin treatment in mood disorders.
Miskowiak KW; Vinberg M; Glerup L; Paulson OB; Knudsen GM; Ehrenreich H; Harmer CJ; Kessing LV; Siebner HR; Macoveanu J
Psychol Med; 2016 Jun; 46(8):1679-91. PubMed ID: 26996196
[TBL] [Abstract][Full Text] [Related]
7. Testing the antidepressant properties of the peptide ARA290 in a human neuropsychological model of drug action.
Cerit H; Veer IM; Dahan A; Niesters M; Harmer CJ; Miskowiak KW; Rombouts SA; Van der Does W
Eur Neuropsychopharmacol; 2015 Dec; 25(12):2289-99. PubMed ID: 26431906
[TBL] [Abstract][Full Text] [Related]
8. Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.
Miskowiak KW; Vinberg M; Harmer CJ; Ehrenreich H; Knudsen GM; Macoveanu J; Hansen AR; Paulson OB; Siebner HR; Kessing LV
Trials; 2010 Oct; 11():97. PubMed ID: 20942940
[TBL] [Abstract][Full Text] [Related]
9. Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder.
Victor TA; Furey ML; Fromm SJ; Öhman A; Drevets WC
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2195-208. PubMed ID: 23809145
[TBL] [Abstract][Full Text] [Related]
10. Medial prefrontal cortex activity during memory encoding of pictures and its relation to symptomatic improvement after citalopram treatment in patients with major depression.
Roy M; Harvey PO; Berlim MT; Mamdani F; Beaulieu MM; Turecki G; Lepage M
J Psychiatry Neurosci; 2010 May; 35(3):152-62. PubMed ID: 20420766
[TBL] [Abstract][Full Text] [Related]
11. Automatic mood-congruent amygdala responses to masked facial expressions in major depression.
Suslow T; Konrad C; Kugel H; Rumstadt D; Zwitserlood P; Schöning S; Ohrmann P; Bauer J; Pyka M; Kersting A; Arolt V; Heindel W; Dannlowski U
Biol Psychiatry; 2010 Jan; 67(2):155-60. PubMed ID: 19748075
[TBL] [Abstract][Full Text] [Related]
12. Effect of acute antidepressant administration on negative affective bias in depressed patients.
Harmer CJ; O'Sullivan U; Favaron E; Massey-Chase R; Ayres R; Reinecke A; Goodwin GM; Cowen PJ
Am J Psychiatry; 2009 Oct; 166(10):1178-84. PubMed ID: 19755572
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant short-term and long-term brain effects during self-referential processing in major depression.
Delaveau P; Jabourian M; Lemogne C; Allaïli N; Choucha W; Girault N; Lehericy S; Laredo J; Fossati P
Psychiatry Res Neuroimaging; 2016 Jan; 247():17-24. PubMed ID: 26655583
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial.
Miskowiak KW; Vinberg M; Christensen EM; Bukh JD; Harmer CJ; Ehrenreich H; Kessing LV
Neuropsychopharmacology; 2014 May; 39(6):1399-408. PubMed ID: 24322509
[TBL] [Abstract][Full Text] [Related]
15. Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study.
Robertson B; Wang L; Diaz MT; Aiello M; Gersing K; Beyer J; Mukundan S; McCarthy G; Doraiswamy PM
J Clin Psychiatry; 2007 Feb; 68(2):261-7. PubMed ID: 17335325
[TBL] [Abstract][Full Text] [Related]
16. Does a single session of electroconvulsive therapy alter the neural response to emotional faces in depression? A randomised sham-controlled functional magnetic resonance imaging study.
Miskowiak KW; Kessing LV; Ott CV; Macoveanu J; Harmer CJ; Jørgensen A; Revsbech R; Jensen HM; Paulson OB; Siebner HR; Jørgensen MB
J Psychopharmacol; 2017 Sep; 31(9):1215-1224. PubMed ID: 28351201
[TBL] [Abstract][Full Text] [Related]
17. Brain activation predicts treatment improvement in patients with major depressive disorder.
Samson AC; Meisenzahl E; Scheuerecker J; Rose E; Schoepf V; Wiesmann M; Frodl T
J Psychiatr Res; 2011 Sep; 45(9):1214-22. PubMed ID: 21477817
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration.
Miskowiak K; Inkster B; O'Sullivan U; Selvaraj S; Goodwin GM; Harmer CJ
Exp Brain Res; 2008 Jan; 184(3):313-21. PubMed ID: 17828390
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine.
Furey ML; Drevets WC; Szczepanik J; Khanna A; Nugent A; Zarate CA
Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25820840
[TBL] [Abstract][Full Text] [Related]
20. Short-term escitalopram treatment normalizes aberrant self-referential processing in major depressive disorder.
Komulainen E; Heikkilä R; Nummenmaa L; Raij TT; Harmer CJ; Isometsä E; Ekelund J
J Affect Disord; 2018 Aug; 236():222-229. PubMed ID: 29747140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
